Results for tag: "Diabetic Macular Edema Drug"

Diabetic Macular Edema (DME) is a common complication of diabetes that affects the macula, the central part of the retina responsible for sharp, central vision. DME is caused by the accumulation of fluid in the macula, leading to swelling and blurred vision. Treatment for DME typically involves the use of Optical Disorders Drugs, such as anti-VEGF agents, corticosteroids, and other drugs. Anti-VEGF agents are the most commonly used drugs for DME, as they can reduce the amount of fluid in the macula and improve vision. Corticosteroids are also used to reduce inflammation and swelling in the macula. Other drugs, such as carbonic anhydrase inhibitors, can also be used to reduce fluid accumulation in the macula. The DME Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, Roche, and Bayer. Show Less Read more